These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12843094)

  • 1. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.
    Antunes R; Figueiredo S; Bártolo I; Pinheiro M; Rosado L; Soares I; Lourenço H; Taveira N
    J Clin Microbiol; 2003 Jul; 41(7):3361-7. PubMed ID: 12843094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.
    Chew CB; Herring BL; Zheng F; Browne C; Saksena NK; Cunningham AL; Dwyer DE
    J Clin Virol; 1999 Oct; 14(2):87-94. PubMed ID: 10588451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.
    Swanson P; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2001 Mar; 39(3):862-70. PubMed ID: 11230396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.
    Rouet F; Foulongne V; Viljoen J; Steegen K; Becquart P; Valéa D; Danaviah S; Segondy M; Verhofstede C; Van de Perre P;
    J Virol Methods; 2010 Feb; 163(2):253-7. PubMed ID: 19837114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
    Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
    New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of the LCx HIV RNA quantitative assay--a new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA.
    Troonen H; Grey H; Michel G
    Clin Chem Lab Med; 2002 Jul; 40(7):698-704. PubMed ID: 12241017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A; de Mendoza C; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):256-9. PubMed ID: 10385013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
    Amendola A; Bordi L; Angeletti C; Visco-Comandini U; Abbate I; Cappiello G; Budabbus MA; Eljhawi OA; Mehabresh MI; Girardi E; Antinori A; Ippolito G; Capobianchi MR
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):488-94. PubMed ID: 12473837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of NucliSens EasyQ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia.
    Lam HY; Chen JH; Wong KH; Chan K; Li P; Lee MP; Tsang DN; Yuen KY; Yam WC
    J Clin Virol; 2007 Jan; 38(1):39-43. PubMed ID: 17110162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study.
    Bürgisser P; Vernazza P; Flepp M; Böni J; Tomasik Z; Hummel U; Pantaleo G; Schüpbach J
    J Acquir Immune Defic Syndr; 2000 Feb; 23(2):138-44. PubMed ID: 10737428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients.
    Clarke JR; Galpin S; Braganza R; Ashraf A; Russell R; Churchill DR; Weber JN; McClure MO
    J Med Virol; 2000 Dec; 62(4):445-9. PubMed ID: 11074472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.
    Swanson P; de Mendoza C; Joshi Y; Golden A; Hodinka RL; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2005 Aug; 43(8):3860-8. PubMed ID: 16081923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.